Ledger.Open graph →

SEC Form D · filed December 6, 2022

Lusaris Therapeutics, Inc

Offering

$60.2M

Sold

$60.2M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

Morrisville, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ramin Farzaneh-Far · Morrisville, NCExec Andrew Levin · BOSTON, MAExec · Director Catherine Riesen · Morrisville, NCExec Daniel Grau · Boston, MADirector Edward Monaghan · Morrisville, NCExec · Director · Promoter Neil Buckley · Morrisville, NCExec Ramin Farzaneh-Far · Morrisville, NCExec Andrew Levin · Boston, MAExec · Director Catherine Riesen · Morrisville, NCExec Daniel Grau · Morrisville, NCDirector Edward Monaghan · Morrisville, NCExec · Director · Promoter Neil Buckley · Morrisville, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗